Physiological role of MT1-MMP-mediated, proteolysis-independent signaling in vivo
MT1-MMP 介导的、不依赖于蛋白水解的体内信号传导的生理作用
基本信息
- 批准号:7769518
- 负责人:
- 金额:$ 20.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-03-01 至 2012-02-28
- 项目状态:已结题
- 来源:
- 关键词:AdultAdvocateAffectAgeAlveolarApoptosisBlood VesselsCartilageCell ProliferationChondrocytesCytoplasmic TailDecelerationDefectDevelopmentEpiphysial cartilageGeneticGenetic ModelsGrowthHemopexinIn VitroKnockout MiceKnowledgeLungMatrix MetalloproteinasesMediatingMinorMouse StrainsMusMutant Strains MiceMutationPathologic ProcessesPathologyPeptide HydrolasesPhenotypePhysiologicalPhysiologyProteolysisPublishingRoleSignal TransductionSkeletal DevelopmentTransgenic MiceVascularizationangiogenesisextracellularhuman MMP14 proteinin vivoinsightlong bonemigrationmutantnovelpostnatalpublic health relevanceskeletal
项目摘要
DESCRIPTION (provided by applicant): Membrane-type 1 matrix metalloproteinase (MT1-MMP), a transmembrane proteinase with extracellular catalytic, hemopexin-like (PEX) and hinge domains, and a short cytoplasmic tail, has been implicated in a variety of physiological and pathological processes. Unlike the other MMPs, whose genetic deficiency has minor phenotypic effects, the genetic deficiency of MT1-MMP causes severe defects in skeletal development with marked deceleration of postnatal growth, shortening of long bones, defective vascularization of the cartilage and delayed formation of secondary ossification centers. In addition, MT1- MMP-deficient mice show important defects in alveolar development and adult angiogenesis, and die by 3 weeks of age. It has been proposed that the phenotype of these mice results from the lack of the proteolytic activity of MT1-MMP. Our recently published, extensive studies have shown that MT1-MMP mediates the activation of intracellular signaling by a proteolysis-independent mechanism that stimulates cell proliferation and migration in vitro and in vivo. MT1-MMP activation of intracellular signaling is mediated by a specific sequence of the cytoplasmic tail and independent of the MT1-MMP proteolytic activity. While this novel and unexpected finding does not diminish the well-established importance of the proteolytic activity of MT1-MMP, it strongly advocates a very important role for the signaling mechanism we identified, and indicates that the phenotype of MT1-MMP null mice can result at least in part from lack of MT1-MMP-mediated signaling. The signaling mechanism we discovered is a novel, proteolysis-independent activity of MT1-MMP that may have important roles in chondrocyte proliferation in the growth plates, formation of secondary ossification centers, skeletal and alveolar development, and in adult angiogenesis. Therefore, we propose to study the physiological role of MT1-MMP- mediated intracellular signaling by developing the following Specific Aim: To generate and characterize the phenotype of a transgenic mouse with a subtle mutation that abolishes MT1-MMP-mediated intracellular signaling. We propose to generate a strain of mice expressing a mutation in the MT1-MMP cytoplasmic tail that abolishes the signaling capacity without affecting the proteolytic activity of MT1-MMP, and to compare their phenotype to those of wt and MT1-MMP null mice. We expect that expression of this mutant MT1-MMP will result in a phenotype that partially recapitulates the phenotype of MT1-MMP null mice. Therefore, the analysis of the phenotype of our mutant mice will allow us to understand the role of MT1-MMP-mediated signaling in development, normal physiology and pathology. PUBLIC HEALTH RELEVANCE: We found an unexpected, paradigm-shifting mechanism that controls cell proliferation and migration in vitro and in vivo. Therefore, we propose to generate and characterize a genetic model in mice to understand the role of this novel mechanism in development, normal physiology and in pathology. The knowledge derived from our study can provide important insight into skeletal and pulmonary alveolar development and in blood vessel formation (angiogenesis).
描述(申请人提供):膜型1基质金属蛋白酶(MT1-MMPs)是一种跨膜蛋白,具有细胞外催化、类血球蛋白(PEX)和铰链结构域,以及一条短的细胞质尾巴,参与了多种生理和病理过程。与其他MMPs不同的是,MT1-MMPs的基因缺陷会导致严重的骨骼发育缺陷,表现为出生后生长明显减慢,长骨变短,软骨血管形成缺陷和继发性骨化中心的形成延迟。此外,MT1-MMP缺陷小鼠在肺泡发育和成年血管生成方面表现出重要的缺陷,并在3周龄前死亡。据认为,这些小鼠的表型是由于缺乏MT1-MMP的蛋白分解活性所致。我们最近发表的大量研究表明,MT1-MMP通过一种不依赖于蛋白降解的机制,在体外和体内刺激细胞的增殖和迁移,介导细胞内信号的激活。MT1-MMP胞内信号的激活是由胞浆尾部的特定序列介导的,与MT1-MMP蛋白的降解活性无关。虽然这一新的和意想不到的发现并没有削弱MT1-MMP蛋白分解活性的公认重要性,但它强烈支持我们所确定的信号机制的一个非常重要的作用,并表明MT1-MMP零小鼠的表型至少部分原因是缺乏MT1-MMPs介导的信号。我们发现的信号机制是MT1-MMP一种新的、不依赖于蛋白降解的活性,它可能在生长板软骨细胞的增殖、次级骨化中心的形成、骨骼和牙槽骨的发育以及成人血管生成中发挥重要作用。因此,我们建议通过以下特定目的来研究MT1-MMP介导的细胞内信号的生理作用:建立并鉴定具有微小突变的转基因小鼠的表型,该突变可以取消MT1-MMP介导的细胞内信号。我们建议建立一株表达MT1-MMP胞浆尾突变的小鼠,在不影响MT1-MMP蛋白分解活性的情况下取消信号传递能力,并将它们的表型与wt和MT1-MMP零小鼠的表型进行比较。我们期望这种突变的MT1-MMPs的表达将导致一个表型,部分概括了MT1-MMP零小鼠的表型。因此,对我们的突变小鼠的表型分析将使我们了解MT1-MMPs介导的信号在发育、正常生理和病理中的作用。公共卫生相关性:我们发现了一种意想不到的、范式转换的机制,它控制着细胞在体外和体内的增殖和迁移。因此,我们建议在小鼠身上建立和表征一个遗传模型,以了解这种新的机制在发育、正常生理和病理中的作用。从我们的研究中获得的知识可以为了解骨骼和肺泡发育以及血管形成(血管生成)提供重要的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paolo Mignatti其他文献
Paolo Mignatti的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paolo Mignatti', 18)}}的其他基金
The role of MT1-MMP proteolytic activity in osteogenesis
MT1-MMP 蛋白水解活性在成骨中的作用
- 批准号:
9386911 - 财政年份:2017
- 资助金额:
$ 20.64万 - 项目类别:
NON-PROTEOLYTIC INTERACTIONS OF TIMP-2 AND MT1-MMP
TIMP-2 和 MT1-MMP 的非蛋白水解相互作用
- 批准号:
8768508 - 财政年份:2013
- 资助金额:
$ 20.64万 - 项目类别:
NON-PROTEOLYTIC INTERACTIONS OF TIMP-2 AND MT1-MMP
TIMP-2 和 MT1-MMP 的非蛋白水解相互作用
- 批准号:
8403629 - 财政年份:2009
- 资助金额:
$ 20.64万 - 项目类别:
NON-PROTEOLYTIC INTERACTIONS OF TIMP-2 AND MT1-MMP
TIMP-2 和 MT1-MMP 的非蛋白水解相互作用
- 批准号:
8141806 - 财政年份:2009
- 资助金额:
$ 20.64万 - 项目类别:
NON-PROTEOLYTIC INTERACTIONS OF TIMP-2 AND MT1-MMP
TIMP-2 和 MT1-MMP 的非蛋白水解相互作用
- 批准号:
8034818 - 财政年份:2009
- 资助金额:
$ 20.64万 - 项目类别:
NON-PROTEOLYTIC INTERACTIONS OF TIMP-2 AND MT1-MMP
TIMP-2 和 MT1-MMP 的非蛋白水解相互作用
- 批准号:
8204871 - 财政年份:2009
- 资助金额:
$ 20.64万 - 项目类别:
NON-PROTEOLYTIC INTERACTIONS OF TIMP-2 AND MT1-MMP
TIMP-2 和 MT1-MMP 的非蛋白水解相互作用
- 批准号:
7655070 - 财政年份:2009
- 资助金额:
$ 20.64万 - 项目类别:
Physiological role of MT1-MMP-mediated, proteolysis-independent signaling in vivo
MT1-MMP 介导的、不依赖于蛋白水解的体内信号传导的生理作用
- 批准号:
8264303 - 财政年份:2009
- 资助金额:
$ 20.64万 - 项目类别:
NON-PROTEOLYTIC INTERACTIONS OF TIMP-2 AND MT1-MMP
TIMP-2 和 MT1-MMP 的非蛋白水解相互作用
- 批准号:
7941654 - 财政年份:2009
- 资助金额:
$ 20.64万 - 项目类别:
NON-PROTEOLYTIC INTERACTIONS OF TIMP-2 AND MT1-MMP
TIMP-2 和 MT1-MMP 的非蛋白水解相互作用
- 批准号:
8210232 - 财政年份:2009
- 资助金额:
$ 20.64万 - 项目类别:
相似海外基金
Optimizing Health and Well-Being of Diverse Mothers with IDD and Their Infants During the Perinatal Period: A Virtual Advocate Tool for Data-Driven Supports
优化患有 IDD 的不同母亲及其婴儿在围产期的健康和福祉:用于数据驱动支持的虚拟倡导工具
- 批准号:
10760051 - 财政年份:2023
- 资助金额:
$ 20.64万 - 项目类别:
POSE: Phase II: Advocate Led Long-term Gameplan for Open OnDemand (ALL GOOD)
POSE:第二阶段:倡导者主导 Open OnDemand 的长期游戏计划(一切顺利)
- 批准号:
2303692 - 财政年份:2023
- 资助金额:
$ 20.64万 - 项目类别:
Standard Grant
Capitalising on our differences: A gathering to better understand and advocate for Early Career Health Researchers in Canada
利用我们的差异:更好地理解和倡导加拿大早期职业健康研究人员的聚会
- 批准号:
468168 - 财政年份:2022
- 资助金额:
$ 20.64万 - 项目类别:
Miscellaneous Programs
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10427960 - 财政年份:2022
- 资助金额:
$ 20.64万 - 项目类别:
Evaluating an ACEs-Targeting Advocate Model of a Substance Use Prevention Program
评估药物使用预防计划的针对 ACE 的倡导者模型
- 批准号:
10577074 - 财政年份:2022
- 资助金额:
$ 20.64万 - 项目类别:
The Art of Creation: Using Art-Based Knowledge Translation to Promote and Advocate for a Healthy Start to Life
创造的艺术:利用基于艺术的知识转化来促进和倡导健康的生命开端
- 批准号:
486588 - 财政年份:2022
- 资助金额:
$ 20.64万 - 项目类别:
Studentship Programs
When I am Old, I shall Wear Purple Nail Varnish: Utilising performance art to construct queer spaces that celebrate and advocate for ageing bodies
当我老了,我要涂紫色指甲油:利用行为艺术构建酷儿空间,庆祝和倡导衰老的身体
- 批准号:
2760091 - 财政年份:2022
- 资助金额:
$ 20.64万 - 项目类别:
Studentship
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10621188 - 财政年份:2022
- 资助金额:
$ 20.64万 - 项目类别:
Techquity by FAITH!: A cluster randomized controlled trial to assess the efficacy of a community-informed, cardiovascular health promotion mobile hlth intervention with digital health advocate support
Techquity by FAITH!:一项整群随机对照试验,旨在评估社区知情、心血管健康促进移动 hlth 干预措施在数字健康倡导者支持下的效果
- 批准号:
10891016 - 财政年份:2021
- 资助金额:
$ 20.64万 - 项目类别:
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
自身抗体阳性受试者的 CMV 反应主张抗病毒治疗以预防 T1D
- 批准号:
10230365 - 财政年份:2020
- 资助金额:
$ 20.64万 - 项目类别:














{{item.name}}会员




